Nova Biomedical ANLZR CG OSMO48 ESM15 SCAN W ACC PK FLX2 60360
Nova Biomedical -- Item TECPIM000412225
Please add to cart & request for quote to see the price
Reserve Now
An advanced analyzer designed for comprehensive biochemical analysis in clinical settings, the Nova Biomedical ANLZR CG OSMO48 ESM15 SCAN W ACC PK FLX2 60360 offers precise measurement of glucose, osmolality, and other key parameters to aid in patient diagnosis and treatment.
Benefits/Advantages:
- Accurate results: Ensures reliable and accurate biochemical analysis for improved patient care.
- Comprehensive testing: Covers a wide range of parameters for comprehensive patient assessment.
- Efficient workflow: Streamlines testing processes in clinical laboratories for increased efficiency.
Product Details
Nova Biomedical
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers.
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
With manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan, Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.